STAAR Surgical (STAA) Competitors $18.17 +1.00 (+5.82%) Closing price 04:00 PM EasternExtended Trading$18.28 +0.11 (+0.60%) As of 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STAA vs. HAE, ICUI, XRAY, QDEL, NEOG, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. STAAR Surgical vs. Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Haemonetics (NYSE:HAE) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability. Does the MarketBeat Community believe in HAE or STAA? Haemonetics received 116 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 61.74% of users gave Haemonetics an outperform vote while only 53.82% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformHaemoneticsOutperform Votes40561.74% Underperform Votes25138.26% STAAR SurgicalOutperform Votes28953.82% Underperform Votes24846.18% Do analysts prefer HAE or STAA? Haemonetics currently has a consensus target price of $97.89, suggesting a potential upside of 34.90%. STAAR Surgical has a consensus target price of $24.63, suggesting a potential upside of 35.60%. Given STAAR Surgical's higher probable upside, analysts clearly believe STAAR Surgical is more favorable than Haemonetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haemonetics 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is HAE or STAA more profitable? Haemonetics has a net margin of 9.47% compared to STAAR Surgical's net margin of -6.44%. Haemonetics' return on equity of 23.66% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Haemonetics9.47% 23.66% 8.82% STAAR Surgical -6.44%-3.35%-2.67% Do insiders and institutionals have more ownership in HAE or STAA? 99.7% of Haemonetics shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 1.8% of Haemonetics shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor HAE or STAA? In the previous week, Haemonetics had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 7 mentions for Haemonetics and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.61 beat Haemonetics' score of -0.26 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, HAE or STAA? Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHaemonetics$1.36B2.56$117.56M$3.3121.92STAAR Surgical$279.13M3.22-$20.21M-$1.44-12.61 Which has more volatility & risk, HAE or STAA? Haemonetics has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. SummaryHaemonetics beats STAAR Surgical on 15 of the 19 factors compared between the two stocks. Get STAAR Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STAA vs. The Competition Export to ExcelMetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$898.15M$10.58B$5.57B$8.66BDividend YieldN/A0.96%5.27%4.19%P/E Ratio-44.2333.2227.3420.20Price / Sales3.223.10415.29164.38Price / Cash23.0214.5338.2534.64Price / Book2.302.667.174.73Net Income-$20.21M$224.27M$3.23B$248.00M7 Day Performance5.95%1.87%6.74%4.53%1 Month Performance-6.20%12.76%15.54%10.88%1 Year Performance-52.30%-18.70%32.85%15.20% STAAR Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STAASTAAR Surgical4.1403 of 5 stars$18.17+5.8%$24.63+35.5%-55.6%$899.89M$279.13M-44.32960HAEHaemonetics4.2259 of 5 stars$68.78+1.6%$97.89+42.3%-16.3%$3.30B$1.36B27.082,820Analyst RevisionICUIICU Medical4.6821 of 5 stars$130.54-3.2%$192.67+47.6%+21.5%$3.21B$2.42B-28.5614,500Positive NewsXRAYDENTSPLY SIRONA4.4709 of 5 stars$15.62-2.3%$20.36+30.4%-41.4%$3.11B$3.72B-7.5515,000QDELQuidelOrtho4.6273 of 5 stars$29.65-3.3%$44.33+49.5%-27.5%$2.01B$2.76B-0.987,000Positive NewsNEOGNeogen3.2027 of 5 stars$5.69-2.9%$9.00+58.2%-65.7%$1.23B$906.00M-2.602,110News CoveragePositive NewsAnalyst RevisionCERSCerus3.4136 of 5 stars$1.32+3.9%$3.50+165.2%-17.4%$252.33M$185.14M-12.00290Positive NewsAnalyst RevisionGap UpOSUROraSure Technologies3.2402 of 5 stars$2.85-1.0%$3.00+5.3%-39.0%$213.18M$161.63M19.00840Positive NewsUTMDUtah Medical Products3.2496 of 5 stars$54.73-0.6%N/A-15.4%$177.76M$39.27M13.86180Positive NewsDividend AnnouncementANIKAnika Therapeutics3.9467 of 5 stars$11.45+2.7%$20.00+74.7%-55.3%$164.20M$117.05M-1.72300Positive NewsWSTWest Pharmaceutical Services4.8053 of 5 stars$209.43-0.7%$332.50+58.8%-28.9%$15.05B$2.90B31.3010,700Trending News Related Companies and Tools Related Companies Haemonetics Competitors ICU Medical Competitors DENTSPLY SIRONA Competitors QuidelOrtho Competitors Neogen Competitors Cerus Competitors OraSure Technologies Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STAA) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STAA Stock Free STAA Stock Alerts